Eton Pharmaceutcials
ETON
39 hedge funds and large institutions have $54.9M invested in Eton Pharmaceutcials in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 7 closing their positions.
50% more capital invested
Capital invested by funds: $36.6M → $54.9M (+$18.3M)
1.04% more ownership
Funds ownership: 32.52% → 33.57% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 41 → 39 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
44% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.99M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.4M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$753K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$558K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
+$521K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$1.36M |
| 2 |
AIC
AWM Investment Company
New York
|
-$1.24M |
| 3 |
PCM
Prelude Capital Management
New York
|
-$924K |
| 4 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$245K |
| 5 |
Squarepoint
New York
|
-$181K |
ETON Hedge Fund Activity: Q3 2020 in Review
39 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2020, worth a combined $54.9M — up 50% from $36.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ETON and 5 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 10 added.
The largest buyer was BlackRock, adding an estimated $1.99M. The largest seller was Diametric Capital, cutting an estimated $1.36M.
- 39 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2020, down from 41 in Q2 2020.
- Funds reported $54.9M of Eton Pharmaceutcials stock for Q3 2020, up 50% quarter-over-quarter.
- 5 funds opened new Eton Pharmaceutcials positions in Q3 2020 and 7 closed out, a net change of -2 holders.
- The largest Eton Pharmaceutcials buyer in Q3 2020 was BlackRock, an estimated $1.99M added.
- The largest Eton Pharmaceutcials seller in Q3 2020 was Diametric Capital, an estimated $1.36M sold.
Based on aggregated 13F filings for Q3 2020.